Central Retinal Artery Occlusion With Cilioretinal Artery Sparing After Semaglutide Injection
Authors:
- 1 April 2025
- journal article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 82 (4) , 416
Abstract
This case report highlights a temporal relationship between the use of a glucagon-like peptide-1 receptor (GLP-1) agonist and the occurrence of central retinal artery occlusion.Keywords
This publication has 4 references indexed in Scilit:
- Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed SemaglutideJAMA Ophthalmology, 2024
- GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stageAmerican Journal of Physiology-Heart and Circulatory Physiology, 2024
- Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data StudyAmerican Journal of Ophthalmology, 2024
- Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trialsEndocrine Journal, 2021